Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| MTXMinerals Technologies Inc | $2.21B | — | $2.07B | -2.2% | -$18.4M | $342.2M | $964.9M | Undervalued |
| UAAUnder Armour, Inc. | $2.21B | — | $4.97B | -3.8% | -$495.64M | $395.98M | $1.38B | Fair valued |
| ADUSAddus HomeCare Corp | $2.21B | 20.8× | $1.42B | +23.2% | $95.91M | $99.57M | $108.82M | Fair valued |
| CCUUnited Breweries Co Inc | $2.2B | 19.3× | CLP 2.9T | +13.2% | CLP 176.54B | CLP 707.12B | CLP 49.23B | Fair valued |
| KSSKOHLS Corp | $2.19B | 8.4× | $15.53B | -4.3% | $272M | $821M | $5.97B | Fair valued |
| ESTAEstablishment Labs Holdings Inc. | $2.19B | — | $211.08M | +27.1% | -$51.06M | $71.16M | $263.67M | Fair valued |
| MDPediatrix Medical Group, Inc. | $2.19B | 12.9× | $1.91B | -4.9% | $165.39M | $288.88M | $433.77M | Fair valued |
| MCRIMonarch Casino & Resort Inc | $2.17B | 19.5× | $545.13M | +4.4% | $101.39M | $120.13M | $13.05M | Fair valued |
| CHAChagee Holdings Ltd. | $2.17B | 11.5× | $1.85B | — | $167.47M | $1.09B | $182.22M | Undervalued |
| RLXRLX Technology Inc. | $2.17B | 16.1× | $566.11M | +50.3% | $131.83M | $767.49M | $25.22M | Undervalued |
| AADXApplied Aerospace & Defense, Inc. | $2.16B | — | $498.76M | +24.8% | -$17.02M | $18.11M | $431.54M | Fair valued |
| FCFFirst Commonwealth Financial Corp | $2.16B | 13.1× | $522.91M | +9.4% | $152.3M | $179.64M | $303.61M | Fair valued |
| TILEInterface Inc | $2.15B | 15.0× | $1.39B | +5.4% | $116.1M | $81.53M | $290.4M | Fair valued |
| CMPRCIMPRESS plc | $2.15B | 23.4× | $3.74B | +9.8% | $95.87M | $248.85M | $1.79B | Undervalued |
| AUPHAurinia Pharmaceuticals Inc. | $2.15B | 7.1× | $283.06M | +20.4% | $287.2M | $179.73M | $64.14M | Undervalued |
| ZBIOZenas BioPharma, Inc. | $2.15B | — | $10M | +100.0% | -$377.74M | $196.58M | $845K | Fair valued |
| BLKBBlackbaud Inc | $2.15B | 14.8× | $1.13B | -2.3% | $114.97M | $34.39M | $1.16B | Undervalued |
| ALGTAllegiant Travel CO | $2.14B | 55.6× | $2.32B | +4.8% | -$44.7M | $508.68M | $102.17M | Fair valued |
| URGNUroGen Pharma Ltd. | $2.14B | — | $109.79M | +21.4% | -$153.49M | $79.13M | $196.13M | Fair valued |
| ADMAAdma Biologics, Inc. | $2.13B | 13.5× | $510.17M | +19.6% | $146.93M | $136.02M | $203.89M | Undervalued |